Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.
about
The Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityA cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophenEffect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen.Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport.Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease.Effect of Liver Disease on Hepatic Transporter Expression and Function.In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.Identification of novel MRP3 inhibitors based on computational models and validation using an in vitro membrane vesicle assay.Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease.Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.Asking the Right Questions With Animal Models: Methionine- and Choline-Deficient Model in Predicting Adverse Drug Reactions in Human NASH.Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.Misregulation of membrane trafficking processes in human nonalcoholic steatohepatitis.Organic Solute Transporter OSTα/ß is Over-Expressed in Nonalcoholic Steatohepatitis and Modulated by Drugs Associated with Liver Injury.
P2860
Q28080256-48ED0511-DCFB-47C7-9663-ED92A23C0D92Q28396747-C32EF8A6-D36F-4943-8CEB-660EA31D9639Q33570726-A1D2203B-3743-420C-B02E-27B153ED1B51Q37026910-86669382-9834-42CF-94A4-E2C94E15DE3DQ37184782-05F338B4-A80C-4DE1-817A-E373782C21A6Q38737633-C1769B5C-0D75-4EDD-84B0-68A9372EB333Q38808182-66F3EAC3-CB4E-4AD0-9A36-675C983F7AEFQ38814148-1AB5D884-25C2-423B-AAAB-D42BEC8BA138Q38888365-502EFA71-0A6B-44B6-A5A6-04BB4921D007Q38941229-B1002C6F-DBEA-4AED-A7B2-D2A173BD440BQ39013059-50B4C15B-5053-4EB6-8042-70BFFFA820E4Q39015474-06481BD6-BB2F-4DDA-98B1-34D5B7D6F2C0Q39183375-5FBC28DA-907D-4F8F-92D4-80976C3BDF5BQ47584564-A675CBFD-EBBB-4628-9ABF-B5F9A2D3358FQ47847406-5BCB0092-8469-4DDC-A372-D46AEEFBC8C6Q48228323-6AF74981-33AC-4EEA-A58E-E7097276E5BEQ50116444-AFD911B6-6F1E-47D5-87F9-C5E14D13816C
P2860
Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Altered regulation of hepatic ...... nonalcoholic steatohepatitis.
@ast
Altered regulation of hepatic ...... nonalcoholic steatohepatitis.
@en
type
label
Altered regulation of hepatic ...... nonalcoholic steatohepatitis.
@ast
Altered regulation of hepatic ...... nonalcoholic steatohepatitis.
@en
prefLabel
Altered regulation of hepatic ...... nonalcoholic steatohepatitis.
@ast
Altered regulation of hepatic ...... nonalcoholic steatohepatitis.
@en
P2093
P2860
P356
P1476
Altered regulation of hepatic ...... nonalcoholic steatohepatitis.
@en
P2093
Amy M Bataille
Daniel W Ferreira
H Hesham A-Kader
Jose E Manautou
Mark J Canet
Matthew D Merrell
Nathan J Cherrington
Rhiannon N Hardwick
Robert P Erickson
Sarah N Campion
P2860
P304
P356
10.1124/DMD.114.062703
P577
2015-03-18T00:00:00Z